PD Dr. Hans Jürgen Rech

Einrichtungen, die zum Universitätsklinikum Erlangen gehören Medizinische Fakultät Department of Medicine 3 – Rheumatology and Immunology

Autoinflammation leading to autoimmunity in adult-onset Still’s disease: more than simple coincidence? (2021) Valor-Mendez L, Manger B, Cavallaro AJ, Achenbach S, Schett G, Rech J Journal article The Joint Vasculitis Registry in German-speaking countries (GeVas) – a prospective, multicenter registry for the follow-up of long-term outcomes in vasculitis (2021) Iking-Konert C, Wallmeier P, Arnold S, Adler S, De Groot K, Hellmich B, Hoyer BF, et al. Journal article Advanced machine learning for predicting individual risk of flares in rheumatoid arthritis patients tapering biologic drugs (2021) Vodencarevic A, Tascilar K, Reiser M, Hueber A, Haschka J, Bayat S, Meinderink T, et al. Journal article Sustained clinical remission under infliximab/rituximab combination therapy in a patient with granulomatosis with polyangiitis (2021) Valor-Méndez L, Kleyer A, Rech J, Manger B, Schett G Journal article Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis (2021) O'Neil LJ, Hu P, Liu Q, Islam MM, Spicer V, Rech J, Hueber A, et al. Journal article Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial (2021) Tascilar K, Hagen M, Kleyer A, Simon D, Reiser M, Hueber A, Manger B, et al. Journal article New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension (2021) Stone JH, Spotswood H, Unizony SH, Aringer M, Blockmans D, Brouwer E, Cid MC, et al. Journal article Long-term Safety of Canakinumab in Patients with Autoinflammatory Periodic Fever Syndromes - Interim Analysis of the RELIANCE Registry (2021) Kuemmerle-Deschner J, Henes J, Kortus-Goetze B, Kallinich T, Oommen PT, Rech J, Weller-Heinemann F, et al. Conference contribution Abatacept Reverses Subclinical Arthritis in Patients with High-risk to Develop Rheumatoid Arthritis -results from the Randomized, Placebo-controlled ARIAA Study in RA-at Risk Patients (2021) Rech J, Hueber A, Ostergaard M, Tascilar K, Hagen M, Mendez LV, Kleyer A, et al. Conference contribution Influence of Canakinumab Dosing on Long-term Efficacy and Safety in Patients with Cryopyrin-associated Periodic Syndromes (CAPS)-30-months Interim Analysis of the RELIANCE Registry (2021) Kuemmerle-Deschner J, Kortus-Goetze B, Oommen PT, Janda A, Rech J, Kallinich T, Weller-Heinemann F, et al. Conference contribution